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Abstract
To evaluate the levels of recent thymic emigrant (RTE) CD4+ T cells in HIV-infected children and 
to explore the associations among their frequency, antiretroviral treatment (ART) adherence, and 
CD4+ T cell restoration. The group evaluated comprised 85 HIV-infected patients classified as 
subjects with moderate or severe immunosuppression or as those with no evidence of 
immunosuppression. To evaluate the association between the frequency of RTE CD4+ T cells and 
ART adherence, 23 of the 85 patients were evaluated at two different time points during a one-
year follow-up period. Children with severe immunosuppression had lower frequencies of RTE 
CD4+ T cells compared with children without evidence of immunosuppression (P<0.001). The 
frequency of RTE CD4+ T cells in children with a high rate of adherence was significantly higher 
(P<0.05) than that observed among those with suboptimal adherence. The latter group presented 
with infectious intercurrences on admission that decreased after initiation of treatment along with 
improved CD4+ and RTE naïve CD4+ T cells counts. The adequate ART adherence is essential for 
immune reconstitution, which might be reflected by the levels of RTE CD4+ T cells. 
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Introduction
The gradual depletion of CD4+ T cells and chronic immune activation are central aspects of 
human immunodeficiency virus (HIV) pathogenesis and are associated with alterations in the 
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antiretroviral treatment (ART) is directly associated with correct adherence 3-5. Immune 
reconstitution after therapy, particularly in children, involves naïve CD4+ T cells due to their more 
effective production of these cells in this developmental period; however, in adults, the 
reconstitution of the naïve CD4+ T cell pool is achieved by the expansion of existing peripheral 
naïve T cells 6-8. 
CD31, also known as platelet cell adhesion molecule 1 (PECAM 1), is a 130 kDa surface 
glycoprotein that belongs to the immunoglobulin superfamily. This molecule is involved in the 
migration of cells through the endothelium cell junction and mediates cell-to-cell adhesion. CD31 
is expressed on a variety of cell types, including thymocytes, lymphocytes, endothelial cells, 
circulating monocytes, and granulocytes. 
Because CD31 is expressed on the majority of thymic cells and in 85% percent of CD4+ T cells 
from cord blood, this molecule was selected as a useful marker of recent thymic emigrants (RTE). 
In addition, the presence of CD31 typifies naïve CD4+ T lymphocytes that have not undergone 
significant homeostatic proliferation after their exit from the thymus 9-14. In previous studies, in 
order to identify additional markers for monitoring treatment and disease progression in children 
with HIV/AIDS, we have shown variations in naïve and other CD4+ T cell subsets levels 15-16.
The aim of the present study was to evaluate, through the expression of CD31, the levels of RTE 
CD4+ T cells in children with different degrees of immunosuppression. In addition, we explored 




The group of children and adolescents evaluated comprised 84 mother-to-child HIV-infected 
patients (40 boys and 44 girls, aged between 18 months and 13 years) and 1 male adolescent with 
horizontal infection treated at the authors’ College Hospital. HIV infection was confirmed by 
enzyme-linked immunosorbent assay (ELISA), western blot analysis and virologic assays. Patients 
were selected on the basis of their clinical and immunological status according to the Centers for 
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were divided into two groups (Table 1): Group A included subjects who were moderately or 
severely immunosuppressed (i.e., CD4+ T cells < 24% of total lymphocytes, n = 40), and Group B 
included subjects with no evidence of immunosuppression (i.e., CD4+ T cells ≥ 25% of total 
lymphocytes, n = 45). To evaluate the association between the frequency of RTE CD4+ T cells and 
adherence to ART, 23 of the 85 HIV-infected children were evaluated at two different time points 
during an average one-year follow-up period. Control samples were obtained from 10 HIV-
seronegative healthy children, aged between 22 months and 14 years, among children coming to 
the hospital as controls for studies of programmed traumatology surgeries. All patients were 
evaluated clinically and for their HIV RNA levels.
 Antiretroviral treatment included nucleoside reverse transcriptase inhibitors (NRTIs), protease 
inhibitors (PI) and non-nucleoside reverse transcriptase inhibitors (NNRTIs). Adherence was 
monitored through surveys and the counting of administered medication. The criteria provided by 
the World Health Organization (WHO) were used as a guide to estimate adherence to treatment. 
Adequate compliance was considered when the adherence to treatment was equal to or greater 
than 95% 3. Written informed consent was obtained from the parents of all participants. The study 
was performed in accordance with the ethical guidelines of the 1975 Declaration of Helsinki and 
approved by the Institution Ethical Committee (registration number 599/15).
RTE CD4+ T cell phenotyping                                                  
Phenotypic analysis was performed on whole blood by using the following monoclonal antibodies: 
CD4 and CD8 [peridinin chlorophyll (PerCP)], CD45 and CD45RA [fluorescein isothiocyanate 
(FITC)], CD14, CD31 and CD62L [phycoerythrin (PE)], all from BD Biosciences (San Jose, CA, 
USA). The isotype antibodies were used as negative staining controls. The viability of the cells 
was evaluated by trypan blue staining, and the viability range was observed to be higher than 90%. 
The data were acquired on a FACS Calibur cytometer (Becton Dickinson, Franklin Lakes, NJ, 
USA) and analysed with CellQuest software (Becton Dickinson). CD4+ T cells were defined as 
naïve (CD4+CD45RA+CD62L+), RTE (CD4+CD45RA+CD31+), central memory (CD4+CD45RA—
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Plasma HIV RNA viral load 
The HIV RNA level was determined using Nuclisens EasyQ HIV-1 version 2 (bioMérieux, Marcy 
l’Etoile, France). The results are expressed as log10 of the number of IU/ml, with a detection 
threshold of 50 IU/ml (i.e., log <1.70). 
Statistical analysis
The normality of the variable distribution was assessed by using the Kolmogorov-Smirnov 
criterion. Analysis of variance (ANOVA) and the Student-Newman-Keuls test were applied to 
compare the levels of CD45RA+CD31+CD4+ T cells among the different clinical groups evaluated. 
Student's t test or the Mann-Whitney test of paired samples was used as appropriate to compare 
the total RTE CD4+ T cells and HIV viral load at the two time points of the longitudinal follow-
up. Proportions were compared by Fisher’s exact test. P < 0.05 was considered statistically 
significant. All statistical analyses were carried out using the GraphPad Prism 5.0 software.
Results
Immune and virological characteristics of the study participants 
The main immune and virological characteristics of the entire study population are summarized in 
Table 1. All except one of the 85 paediatric patients acquired HIV infection by vertical 
transmission, but no prophylactic measures were applied in the HIV-infected mothers, neither 
during pregnancy nor during delivery. The ages of diagnosis in the children with moderate or 
severe immunosuppression (i.e., Group A) were similar to those without evidence of 
immunosuppression (i.e., Group B) (range = 1.4–15 and 3–14 years, respectively). The children 
with no evidence of immunosuppression had a longer time on ART associated with higher levels 
of CD4+ nadir T cells and a higher proportion of children with a viral load below the level of 
detection compared with the children with moderate or severe immunosuppression (Table 1). The 
children in Group A had diminished CD4+ T cell counts whereas naïve CD4+ T cells were 
diminished both as percentages and counts. In contrast, the percentages of central and effector 
memory CD4+ T cells were higher, and CD4+ T cell counts of these subsets were lower, in Group 
A compared with Group B (Table 1). Terminally differentiated CD4+ T cell counts were also 
decreased in Group A. As expected, CD8+ T cell percentages and counts were increased in 
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A group of 23 patients was also evaluated at two different time-points, with an average follow-up 
period of 12 months (range, 6–15 months). Seven of these patients were already receiving the 
appropriate ART, with correct adherence, while 8 patients presented with virological failure due to 
deficient adherence to treatment. Of the remaining 8 patients, HIV infection had recently been 
diagnosed in 3 children, and thus, they were naïve of treatment at inclusion, while the other 5 
children restarted ART after a variable period of abandonment.
Decreased number of RTE CD4+ T cells in the peripheral blood of HIV-infected children 
The frequency of recent thymic emigrant CD4+CD45RA+CD31+ T cells was quantified in 85 HIV-
infected children and adolescents. A diagram of the flow cytometry gating strategy and 
representative dot-plots of the RTE CD4+ T cells in the HIV-infected children with moderate or no 
signs of immunosuppression and uninfected controls are shown in Figure 1. Lower percentages of 
CD4+CD45RA+CD31+ T cells were recorded in the HIV-infected children compared with the 
uninfected controls. The children with moderate or severe immunosuppression also had lower 
percentages (Figure 2A) and absolute counts (Group A, median= 106 cells/µL), range= 60–181; 
Group B, median= 473 cells/µL), range= 334–652) of CD4+CD45RA+CD31+ T cells compared 
with the children without evidence of immunosuppression. 
Monitoring of RTE CD4+ T cells in HIV-infected children under retroviral treatment. 
The decreased percentage of RTE CD4+ T cells found in the subjects with moderate or severe 
immunosuppression prompted us to investigate whether changes in the levels of this T subset were 
linked to the efficacy of and adequate adherence to antiretroviral treatment. To address this issue, 
CD4+CD45RA+CD31+ T cells were prospectively measured in 23 HIV-infected children during a 
12-month follow-up period. According to the time of implementation of treatment and the rate of 
treatment adherence, the patients were divided into 3 groups: AD1 comprised patients who were 
already receiving the appropriate ART with a high adherence rate, and AD2 comprised treatment-
naïve patients who had been recently diagnosed with HIV infection and started treatment after 
recruitment, as well as patients who had discontinued ART and reinitiated treatment after 
recruitment. Both subgroups of patients included in the AD2 group had a high adherence rate 
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receiving ART but with detectable levels of viral load due to deficient treatment adherence. 
Despite changes in the ART schedule according to the results of a genotyping test, a low 
adherence rate was maintained during follow-up.
In the children of the AD1 group, who maintained a high number of CD4+ T cells and an 
undetectable viral load, RTE CD4+CD45RA+CD31+ T cells did not show significant changes 
during follow-up (Table 2, Figure 2B). However, in 4 out of 7 patients, the frequencies at 12 
months of follow-up were in the range of those observed in uninfected controls (Figure 2B). In the 
AD2 patients, a significant increase in CD4+ T cells and a decrease in viral load were 
accompanied by a significant increase in RTE and total naïve CD4+ T cells following 12 months 
of follow-up (Table 2, Figure 2B). In contrast, the group of non-adherent patients (NA) presented 
decreased levels of CD4+ T cells, high viral loads and decreased values of RTE and total naïve 
CD4+ T cells, which were all maintained during follow-up (Table 2, Figure 2B). Of note, the 
frequency of RTE CD4+ T cells in the children with a high rate of adherence (i.e., groups AD1 and 
AD2) were significantly higher than those observed in the children with a low rate of adherence 
(i.e., NA) regardless of the time point assessed (Figure 2B). 
Association between infectious intercurrence and ART adherence rate in HIV-infected children.
We then assessed the extent to which the rate of treatment adherence and virological response 
were associated with the presence of infectious intercurrences during the follow-up period. None 
of the children in the AD1 group presented with relevant infectious pathology during the follow-
up period. In contrast, 75% of the patients in the AD2 group presented with some kind of 
infectious intercurrence on admission. Of note, two adolescents included in the AD2 group 
showed intercurrences at admission. One of these patients was the only patient at inclusion with a 
recent diagnosis of HIV for sexual transmission, co-infected with acquired syphilis, while the 
second patient, infected by mother-to-child transmission, was diagnosed late, at twelve years of 
age, and had pneumonia. After the initiation of treatment and with the achievement of an 
appropriate immune and virological response, the AD2 patients were free from infectious 
processes at the end of the study period. Two patients of the AD2 group and one non-adherent 
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pneumonia-oral candidiasis were the simultaneous intercurrences in the patients of the AD2 group 
at the initiation of the study, whereas Microsporidium spp. diarrhoea-oral candidiasis was 
observed in a non-adherent patient. Moreover, oral candidiasis was recurrent in one patient in the 
NA group, while three other children in this group presented with and maintained different 
infectious comorbidities, such as recurrent herpes zoster infection or relapse of pulmonary 
infection due to Mycobacterium tuberculosis. It is worth noting the decrease in the number of 
infectious conditions, especially in the lungs and mouth, in the eight patients in the AD2 group 
after initiation of treatment (Table 3).
Discussion
The number and functional characteristics of the different lymphocyte subsets present alterations 
during the course of HIV infection. Progressive immune exhaustion is a much more complex 
process than a simple reduction in the number of CD4+ T lymphocytes, with striking differences 
observed in the natural course of the infection between children and adults 18. In adults, circulating 
viral levels reach their peak during the acute infection phase and decrease after 6 or 8 weeks, and 
occasionally, the viral load can be maintained at undetectable levels for years. In contrast, in 
children without therapy, the viral load reaches very high levels during the first two years of life 
and does not decrease as quickly as in adults 19. 
In this observational study, we evaluated whether RTE cells varied not only between the  
immunological categories but also with the degree of adherence in HIV-infected children. We 
showed that the children with moderate or severe immunosuppression had the lowest levels of 
RTE and that a correct adherence promoted the restoration of thymic function and decreased the 
presence of comorbidities and intercurrences in HIV-infected children. 
The children with severe immunosuppression had lower levels of naïve and RTE 
CD4+ T cells compared with the children with no evidence of immunosuppression. These findings 
are probably due to an enhanced need for the recruitment of RTE to regenerate mature naïve T 
cells in patients with major homeostatic disturbances compared with those in more stable 
conditions in which cell loss and cell production appeared more balanced 20, 21. The children with 
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counts but lower percentage levels of these subsets compared with the children with severe 
immunosuppression. This discrepancy might be accounted for by the fact that children with better 
clinical conditions had higher total CD4+ T cell counts. 
Protracted basal activation of the immune system in response to HIV infection, which cannot be 
completely neutralized by the action of ART, could be related to the incomplete normalization of 
RTE CD4+ T cells observed in this study in children without evidence of immunosuppression. An 
inverse correlation between the levels of RTEs and activated CD8+ T cells was observed in HIV-
infected adolescent 22 and adult patients 23. Altered thymic function might be secondary to HIV 
infection due to the production of inhibitory cytokines and an increased conversion of naïve cells 
into memory T cells 9. Of note, in the children with correct treatment adherence, the number of 
RTE CD4+ T cells increased along with the number of total naïve CD4+ T cells. 
The longitudinal monitoring of RTEs allowed us to relate the response to therapy and the 
conditions of adherence to ART with the values of RTEs. The children with sustained adherence 
had the highest levels of RTEs, which remained stable during the follow-up period, contrasting 
with the constantly low RTE cells in the non-adherent children. These findings support the 
hypothesis that only sustained control of the viral load can restore thymic function. However, the 
introduction of ART followed by correct adherence was able to significantly improve RTEs levels 
during follow-up although not to the levels of the patients who had sustained adherence over more 
than eight years or to the levels found in uninfected children. This finding indicates that a 
prolonged and continuous high level of adherence would probably be necessary to permit a 
complete reconstitution of the immune system, although a significant reduction in the number of 
patients who presented with intercurrences was observed during the time of follow-up in the 
children with a better rate of adherence. Moreover, the two adolescents who had good adherence 
did not recover RTEs at the same rate as younger children (data not shown), supporting the 
hypothesis that a highly active thymus in early childhood may contribute to better immune 
reconstitution if ART is initiated early in life. In line with our findings, adult HIV/HCV co-
infected patients show lower levels of RTEs than single HIV-infected subjects 24.
RTE T cells have also been identified by molecular biology techniques by analysing the excision 
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and the frequency of RTE naïve CD4+ T cells have been described in different pathologies 27-29, 
confirming the use of CD31 as a marker of thymic production. 
One limitation of the study is that the follow up evaluation of RTE in patients with different rates 
of adherence was performed in only a small patient group. Functional reconstitution is the 
fundamental objective of ART, since it allows the immune system to perform its key functions, 
such as protection against opportunistic microorganisms. Achieving the restoration of immune 
function with adequate competence to control successive infectious challenges will result in the 
best quality of life of HIV-infected children. This last goal can only be achieved through the 
commitment of the parents and guardians of this vulnerable population to the responsible 
administration of ART.
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Table 1. Clinical and immunological characteristics of the full study population
Variables Group A Group B Co P value
(n= 40) (n= 45) (n= 10)
Sex (males/total) 19/40 22/45 5/10
Age A (years) 11.2 (1.4-15) 9.3 (3-14) 10.5 (1.8-14)          
Time on ART A (years) 3.74 (0-11) 7.97 (1-11) ND           A vs B <0.05
Time untreated A (years) 5.91 (1.5-11) 2.75 (1.5-9) ND           A vs B < 0.05
HIV RNA A (Log 10 3.24 (1.81-4.67)  1.91 (<1.70-2.53) ND           A vs B < 0.05
copies/mL)
No. of children with 8 (20) 35 (78) ND A vs B < 0.001
VL Log 10 < 1.70 (%)
Lymphocyte count A             2905 (1072-4702) 3101 (1023-4093) 2700 (2100-3300)         
(cells/µL)
CD4+ T cells A (%) 11 (8-18) 37 (31-43) 47 (40-56) A vs B, A vs Co < 0.05
CD4+ T cell count A        423 (72-762) 978 (692-1500) 1296 (1080-1512) A vs B, A vs Co < 0.05
(cells/µL)
CD4+ T cells nadir A (%) 9 (3-15) 20 (6-36) ND A vs B < 0.05
Naïve CD4+ T cells A (%)   36 (31-43) 50 (38-64) 55 (49-62) A vs B, A vs Co < 0.05
Naïve CD4+ T cell count A            170 (5-338) 598 (299-913) 712 (582-842) A vs B, A vs Co < 0.05
(cells/µL)
Central memory CD4+ T 45 (33-59) 34 (22-56) 31 (24-36) A vs B, A vs Co < 0.05
cells (%) B vs Co > 0.05
Central memory CD4+ T cell 191 (147-239) 369 (325-421) 400 (387-417) A vs B, A vs Co < 0.05
count (cells/µL)
Effector memory CD4+ T 12 (15-19) 9 (5-14) 3 (1-5) A vs B, A vs Co < 0.05
cells (%)
Effector memory CD4+ T 46 (26-72) 100 (83-115) 39 (36-42) A vs B, B vs Co < 0.05
cell count (cells/µL)
Terminally differentiated 3 (1-5) 3 (1-5) 2 (1-3)
CD4+ T cells (%)
Terminally differentiated  10 (13-17) 24 (16-33) 26 (13-39) A vs B, A vs Co < 0.05
CD4+ T cell count (cells/µL)
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Note. A Data are given as median and range; ND, not done. Group A, subjects with moderate or severe immunosuppression 
(i.e., CD4+ T cells < 24%), Group B, subjects with no evidence of immunosuppression (i.e., CD4+ T cells ≥ 25%). Co, 
uninfected controls. Comparisons among groups were performed by ANOVA.
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Table 2. Immune and virological characteristics of 23 HIV-infected children with different rates of ART adherence
Variables A AD1 (n= 7) AD2 (n= 8) NA (n= 8)
t0 t1 t0 t1 t0 t1
CD4 (%) 33 (18-48) 33(20-46) 16 (4-26) B 29(19-39) 16(4- 19) 19(7-21
CD4+ T cell count 1461(1045-1877) 1237 (786-1688) 268 (38-614) B 749 (200-1338) 314 (177-541) 392 (175-609)
(cells/µL)
Log VL < 1.70 <1.70 4.9 (2.84-6.34) B <1.70 3.90 (2.4-4.87) 3.36 (2.56-3.99)
Naïve CD4+ T cells (%) 54(43-66) 62 (51-80) 39 (24-58) B 55 (41-69) 34 (11-49) 32 (19-60)
Naïve CD4+ T cell count 719 (492-1106) 787 (308-1346) 90 (13-215) B 397 (154-840) 121 (20-211) 157 (28-311)
(cells/µL)
CD4+CD45RA+CD31+ (%) 1.27 (1-2.33) 2.63 (1.75-7) C 1.34 (0.33-1.60)
(Ratio t1/t0)
CD4+CD45RA+CD31+ 0.90 (0.57-1.10) 5.26 (2.87-17.6) C 1.44 (0.21-2.68)
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(Ratio t1/t0)
                                                                                                                                                                                                                                                                   
Notes. A Data are given as median and range. AD1, patients receiving ART with good adherence; AD2, treatment-naïve patients recently diagnosed with HIV 
infection, or patients with discontinued ART that restarted treatment; NA, patients with a low adherence rate. B P < 0.05 vs. t1 by paired comparison; C P < 0.05 vs. 
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Table 3. Infectious intercurrences in 23 HIV-infected children with different rates of ART adherence.
       AD1 AD2         NA
Patient groups A (n)          7 8          8
Age at inclusion 
Median years (range)                                    




       12.5 
      (5-17)
Years of ART at inclusion
Median (range)
       8.1 
     (4-17)
0         9.2  
      (3-16)
No. of comorbidities B
    t0        t1        t0             t1     t0              t1
Oral candidiasis 0     0 2               0      2                 1
Pneumonia 0          0 3               0      0                 0
Ocular toxoplasmosis 0          0 1               0      0                 0
Herpes zoster 0          0 1               0      1                 1 
Pulmonary tuberculosis 0          0 1               0      1                 1  
Diarrhoea (Microsporidium spp.) 0          0     0               0      1                 1  
Acquired syphilis 0          0 1               0      0                 0
No. of patients with
comorbidities (%) 
   0 (0)    0 (0) 6 (75) C     0 (0)   4 (50) D     4 (50)
A AD1, patients receiving ART with a high adherence rate; AD2, treatment-naïve patients recently 
diagnosed with HIV infection or patients with discontinued and subsequently reinitiated ART with a high 
adherence rate during follow-up; NA, patients receiving ART with deficient adherence. B Patients were 
evaluated at two different time points (t0–t1) with an average follow-up of 12 months. C Two AD2 patients 
presented with pneumonia-herpes zoster infection and pneumonia-oral candidiasis simultaneously. D One 
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Figure legends
Figure 1. Flow cytometry gating strategy and representative dot-plots of RTE naïve CD4+ T cells 
in HIV-infected children and uninfected controls. Whole blood was stained with CD4, CD45RA 
and CD31 monoclonal antibodies and analysed by flow cytometry. A, An R1 gate was set on the 
lymphocytes based on the forward scatter (FSC) versus the side-scatter (SSC) dot plot. CD4+ T 
cells were then selected (R2) in a side-scatter (SSC) versus CD4 dot-plot. B, The expression of 
CD45RA+CD31+ on CD4+ T cells was then analysed by joining the R1 and R2 gates. Group A, 
subjects moderately or severely immunosuppressed; Group B, subjects with no evidence of 
immunosuppression, as defined in the Materials and Methods. The numbers indicate the 
percentages of CD4+CD45RA+CD31+ T cells.
Figure 2. Frequency of RTE naïve T cells in HIV-infected paediatric patients under antiretroviral 
treatment. Whole blood was collected, stained with anti-CD4, anti-CD45RA and anti-CD31 
monoclonal antibodies and analysed by flow cytometry. CD4+ T cells were gated by side-scatter 
(SSC) versus CD4 dot-plot, and the frequency of CD4+CD45RA+CD31+ T cells was measured 
according to CD4+ T cell percentages. Boxes represent values between the 25th and 75th 
percentiles and medians; bars indicate 10th and 90th percentiles. A) Group A, subjects moderately 
or severely immunosuppressed; Group B, subjects with no evidence of immunosuppression, as 
defined in the Materials and Methods. ANOVA and the Student-Newman-Keuls test were applied 
for statistical analysis. B) The frequency of CD45RA+CD31+CD4+ T cells was determined at two 
different time points during an average follow-up period of 12 months. HIV-infected children 
were grouped according to their levels of CD4+ T cells and viral load at inclusion (i.e., time 0), as 
defined in the Materials and Methods. ** P< 0.001 vs. t1 AD2; * P< 0.05 vs. AD1; AD2 and NA 
groups, at time 0 and time 1 of follow-up. Paired and unpaired Student's test was used for 
statistical analysis. 
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